These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16470210)

  • 1. Treatment of Peyronie's disease with oral pentoxifylline.
    Brant WO; Dean RC; Lue TF
    Nat Clin Pract Urol; 2006 Feb; 3(2):111-5; quiz 116. PubMed ID: 16470210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.
    Paulis G; De Giorgio G
    J Med Case Rep; 2022 Oct; 16(1):359. PubMed ID: 36207748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
    Alizadeh M; Karimi F; Fallah MR
    Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
    Gallo L; Sarnacchiaro P
    Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.
    Safarinejad MR; Asgari MA; Hosseini SY; Dadkhah F
    BJU Int; 2010 Jul; 106(2):240-8. PubMed ID: 19863517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the type of the Peyronie's curvature effect penile vascular parameters in normopotent men?
    Metin A; Kayigil O; Atmaca AF; Ahmed SI
    Arch Androl; 2005; 51(3):165-70. PubMed ID: 16025854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline treatment and penile calcifications in men with Peyronie's disease.
    Smith JF; Shindel AW; Huang YC; Clavijo RI; Flechner L; Breyer BN; Eisenberg ML; Lue TF
    Asian J Androl; 2011 Mar; 13(2):322-5. PubMed ID: 21102473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of penile ultrasound in Peyronie's disease.
    McCauley JF; Dean RC
    World J Urol; 2020 Feb; 38(2):263-268. PubMed ID: 31606787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
    Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
    J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [La Peyronie's disease: anatomical and functional evaluation using color Doppler echography].
    Pagliarulo G; Ludovico GM; Giocoli Nacci G; Curatolo C; Pagliarulo A
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):159-61. PubMed ID: 9162351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with Peyronie's disease: ultrasonographic features.
    Machiels F; De Maeseneer M; Goes E; Braeckman J; Osteaux M
    J Belge Radiol; 1997 Aug; 80(4):172. PubMed ID: 9351309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duplex ultrasound findings in men with Peyronie's disease.
    Lopez JA; Jarow JP
    Urol Radiol; 1991; 12(4):199-202. PubMed ID: 2042271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penile sonoelastography for the localization of a non-palpable, non-sonographically visualized lesion in a patient with penile curvature from Peyronie's disease.
    Richards G; Goldenberg E; Pek H; Gilbert BR
    J Sex Med; 2014 Feb; 11(2):516-20. PubMed ID: 24261857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between penile fracture and Peyronie's disease: a prospective study.
    Acikgoz A; Gokce E; Asci R; Buyukalpelli R; Yilmaz AF; Sarikaya S
    Int J Impot Res; 2011; 23(4):165-72. PubMed ID: 21654815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of non-surgical treatment options for Peyronie's disease.
    Larsen SM; Levine LA
    Int J Impot Res; 2012; 24(1):1-10. PubMed ID: 21918530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
    Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
    J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New conception of surgery in Peyronie's disease].
    Kovalev VA; Karaguzhin SG; Koroleva SV; Abdulkhamidov AN; Levadnaia MG
    Urologiia; 2009; (5):45-8. PubMed ID: 20209870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
    Paulis G; Brancato T
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.